TD ASSET MANAGEMENT INC - ADVERUM BIOTECHNOLOGIES INC ownership

ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 157 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q4 2020. The put-call ratio across all filers is 1.58 and the average weighting 0.3%.

Quarter-by-quarter ownership
TD ASSET MANAGEMENT INC ownership history of ADVERUM BIOTECHNOLOGIES INC
ValueSharesWeighting
Q1 2021$629,000
+13.7%
63,827
+25.1%
0.00%0.0%
Q4 2020$553,000
+23.4%
51,001
+17.2%
0.00%0.0%
Q3 2020$448,000
-70.8%
43,501
-40.8%
0.00%
-50.0%
Q2 2020$1,535,000
+116.5%
73,501
+1.3%
0.00%
+100.0%
Q1 2020$709,000
+8.9%
72,538
+28.3%
0.00%0.0%
Q4 2019$651,000
+98.5%
56,550
-6.1%
0.00%0.0%
Q3 2019$328,000
+88.5%
60,250
+312.7%
0.00%
Q2 2019$174,00014,6000.00%
Other shareholders
ADVERUM BIOTECHNOLOGIES INC shareholders Q4 2020
NameSharesValueWeighting ↓
Sonic Fund II, L.P. 4,112,355$40,178,00034.81%
Versant Venture Management, LLC 7,068,233$69,056,636,00018.94%
ACUTA CAPITAL PARTNERS, LLC 1,704,500$16,653,0008.07%
Soleus Capital Management, L.P. 313,900$3,067,0003.57%
Ghost Tree Capital, LLC 1,305,500$12,755,0003.38%
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) 480,000$4,690,0002.97%
RTW INVESTMENTS, LP 6,631,627$64,791,0002.79%
VR Adviser, LLC 994,381$9,715,0002.63%
Avoro Capital Advisors LLC 7,150,000$69,856,0002.36%
RA Capital Management 7,272,714$71,054,0002.24%
View complete list of ADVERUM BIOTECHNOLOGIES INC shareholders